Trial Profile
A pilot study of biologic efficacy and safety of the addition of celecoxib to a program of induction chemotherapy and neo-adjuvant chemo-radiotherapy for the treatment of esophageal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Cisplatin; Irinotecan
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 17 May 2012 Actual patient number 14 added as reported by ClinicalTrials.gov.
- 17 May 2012 Actual patient number 14 added as reported by ClinicalTrials.gov.
- 17 May 2012 Actual end date Sep 2010 added as reported by ClinicalTrials.gov.